You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 12, December 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE ANNUAL MEETING OF THE SOCIETY OF SURGICAL ONCOLOGY, LONDON, APRIL 27 TO APRIL 30, 1987-PART II
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Expression of Autoantigens in Human Colorectal Carcinomas

Implications for a Generic Vaccine

J. Milburn Jessup, MD; Kefeng Qi, MB; Kristine Kanellopoulos; Debra E. Campbell; Karen R. Cleary, MD; Catherine M. Hickey; Christopher L. Reading, PhD; Howard E. Savage, PhD

Arch Surg. 1987;122(12):1435-1439.


Abstract

• The antibody response of patients was used to characterize the autoantigens in human colorectal carcinoma. Twenty-seven primary and 13 metastatic carcinomas with paired normal tissues were extracted and transferred onto nitrocellulose membranes by the Western transfer technique. After the transfers were incubated with the serum of the patient from whom the tumor was derived, autoantigens were indentified by indirect immunoperoxidase staining. All tumors contained at least one autoantigen. Six tumor-associated autoantigens, ranging in molecular weight from 26 to 58 kilodaltons (kD), were identified by antibodies in 25% or more of the sera. Eleven metastases expressed a 41-kD autoantigen that was present in only a third of the extracts of normal liver or lung. Thus, the number of dominant polypeptide autoantigens in colorectal carcinoma is restricted to six molecules. These autoantigens may be organ-associated antigens that are expressed by neoplastic cells. The 41-kD autoantigen may be a potential marker for metastases. A generic vaccine appears to be feasible for colorectal carcinoma since the number of dominant antigens is limited.

(Arch Surg 1987;122:1435-1439)



Author Affiliations

From the Departments of Surgery (Drs Jessup and Qi, and Mss Kanellopoulos and Campbell), Pathology (Dr Cleary), and Hematology (Ms Hickey and Dr Reading), The University of Texas M. D. Anderson Hospital and Tumor Institute, Houston; and Immunology Research Laboratory, Veterans Administration Medical Center, Houston; and Department of Immunology and Microbiology, Baylor College of Medicine, Houston (Dr Savage).


Footnotes

Accepted for publication Aug 24, 1987.

Read before the Annual Meeting of the Society of Surgical Oncology, London, April 30, 1987.

Reprint requests to Department of Surgery, Box 106, The University of Texas M. D. Anderson Hospital and Tumor Institute, 1515 Holcombe Blvd, Houston, TX 77030 (Dr Jessup).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Carcinoembryonic Antigen Enhances Metastatic Potential of Human Colorectal Carcinoma
Hostetter et al.
Arch Surg 1990;125:300-304.
ABSTRACT  

Tumor Immunization: Improved Results After Vaccine Modified With Recombinant Interferon Gamma
Sigal et al.
Arch Surg 1990;125:308-312.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.